Stock Taper
SCREENER COMPARE ANY 2 STOCKS
PDSB
PDS BIOTECHNOLOGY CORPORATION
NASDAQ
$0.22
▲ UP 4.60% (0.01)

KEY STATISTICS

Market Cap$12.22 M
52w High$1.55
52w Low$0.20
Dividend Yield—
Frequency—
P/E-0.33
Volume2.93M
Shares Out.55.92M

COMPANY

LEADERSHIP

Frank K. Bedu-Addo
CHIEF EXECUTIVE
Frank K. Bedu-Addo

COMPENSATION 2026

Salary$356,250
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$0
Total$2,583,760

ABOUT

SECTOR
Healthcare
WENT PUBLIC
September 30, 2015
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
21

PRICE TARGET

Target High$9.00
Target Low$9.00
Target Median$9.00
Target Consensus$9.00

UPCOMING EARNINGS

DateNov 12, 2026
DayThursday
Rev. Est.—
NOV
12
THU

SPLIT RECORD

DATETYPERATIO
2019-03-18Reverse1:20

PRICE

$0.22 ▲ UP 4.60% (+$0.01)
OVERLAYS
$0.21$0.22$0.23$0.239:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM0.22

About PDS Biotechnology Corporation

https://www.pdsbiotech.com ↗

PDS Biotechnology, a clinical-stage biopharma founded in 2005, develops multifunctional cancer immunotherapies and vaccines, with lead candidates in Phase II trials and collaborations with NIH, Merck, HHS, and MSD.

INDUSTRY

Biotechnology

A PRODUCT PDS BIOTECHNOLOGY CORPORATION IS KNOWN FOR

PDS0101
PDS0101

An investigational T-cell activating immunotherapy designed to treat various HPV-positive cancers. As the company's lead candidate in a pivotal Phase 3 clinical trial, it represents PDS Biotechnology's most prominent and actively developed product.

COMPETITORS

COMPETITOR
CRBP COMPARE
INO COMPARE
IOVA COMPARE
RCUS COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
13
LISTED HERE
3
RANKED BY POSITION SIZE
VTI
0.00% · 1.0M
IWC
0.00% · 192.4K
TYNE
1.29% · 1.9K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
15.26%
HOLDERS
71
TOP 12 OF 71 · RANKED BY POSITION SIZE
Armistice Capital, LLC
2.8M sh · $2.18M
Vanguard Group Inc
2.0M sh · $1.5M
Geode Capital Management, LLC
660.2K sh · $399.49K
Blackrock, Inc.
554.0K sh · $335.2K
Blackrock Inc.
487.0K sh · $1.43M
Citadel Advisors LLC
386.4K sh · $390.29K
Inspirion Wealth Advisors, LLC
344.4K sh · $1.32M
Blair William & Co/Il
300.0K sh · $181.5K
Squarepoint Ops LLC
291.6K sh · $294.54K
Renaissance Technologies LLC
275.9K sh · $278.62K
Ubs Group AG
251.7K sh · $193.81K
Commonwealth Equity Services, LLC
196.8K sh · $151.49K

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
DIRECTOR, OFFICER: PRESIDENT/CEO
BEDU-ADDO FRANK
Purchase · 548.8K shares
2026-01-12
★
OFFICER: CHIEF SCIENTIFIC OFFICER
CONN GREGORY
Purchase · 150.0K shares
2026-01-12
★
OFFICER: CHIEF MEDICAL OFFICER
Shepard Kirk V.
Purchase · 300.0K shares
2026-01-12
★
OFFICER: CHIEF FINANCIAL OFFICER
Boesgaard Lars
Purchase · 300.0K shares
2026-01-12

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 2
2 GRADES IN THE LAST 12 MONTHS
HC Wainwright & Co. BUY B. Riley Securities BUY

SECTORS PEERS

PEERPRICE
OKUR$3.94COMPARE
ANVS$1.82COMPARE
INMB$2.32COMPARE
XLO$9.23COMPARE
TPST$1.04COMPARE
RVPH$0.48COMPARE